Azerbaijan - Patent Applications 2008
Azerbaijan's patent applications was 226 in 2008, decreased +61 from 287 in 2007. This was the 53rd highest globally.
| Rank | Country | Value | YoY |
|---|---|---|---|
| 1st | Japan | 330,110 | -1.0% |
| 2nd | United States | 231,588 | -4.0% |
| 3rd | China | 194,579 | 27.1% |
| 4th | Korea | 127,114 | -1.2% |
| 5th | Germany | 49,240 | 2.9% |
| 6th | Russian Federation | 27,712 | 0.8% |
| 7th | United Kingdom | 16,523 | -4.9% |
| 8th | Iran, Islamic Republic of | 15,403 | 44.7% |
| 9th | France | 14,658 | -0.4% |
| 10th | Italy | 8,588 | -7.2% |
| 11th | India | 6,425 | 2.0% |
| 12th | Canada | 5,061 | 1.3% |
| 13th | Brazil | 4,280 | 2.1% |
| 14th | Spain | 3,632 | 11.2% |
| 15th | Ukraine | 2,825 | -17.9% |
| 16th | Australia | 2,821 | 3.8% |
| 17th | Sweden | 2,549 | 0.9% |
| 18th | Poland | 2,488 | 4.0% |
| 19th | Netherlands | 2,421 | 16.5% |
| 20th | Austria | 2,298 | -3.6% |
| 21st | Türkiye | 2,221 | 22.7% |
| 22nd | Finland | 1,799 | -0.3% |
| 23rd | Denmark | 1,634 | -1.6% |
| 24th | Switzerland | 1,594 | -5.8% |
| 25th | Israel | 1,528 | -5.4% |
| 26th | Belarus | 1,510 | 7.5% |
| 27th | Kazakhstan | 1,483 | -9.2% |
| 28th | New Zealand | 1,256 | -33.6% |
| 29th | Norway | 1,150 | -6.1% |
| 30th | Romania | 995 | 20.3% |
| 31st | Thailand | 902 | -4.6% |
| 32nd | South Africa | 860 | -6.0% |
| 33rd | Malaysia | 818 | 22.1% |
| 34th | Argentina | 801 | -14.5% |
| 35th | Singapore | 793 | 13.9% |
| 36th | Czechia | 712 | -0.6% |
| 37th | Mexico | 685 | 8.9% |
| 38th | Hungary | 683 | -0.9% |
| 39th | Greece | 628 | 9.2% |
| 40th | Belgium | 575 | 26.7% |
| 41st | Chile | 531 | 31.8% |
| 42nd | Egypt, Arab Republic of | 481 | -6.8% |
| 43rd | Indonesia | 386 | 35.9% |
| 44th | Serbia | 386 | -2.3% |
| 45th | Portugal | 381 | 52.4% |
| 46th | Sudan | 340 | 11,233.3% |
| 47th | Croatia | 330 | -4.1% |
| 48th | Slovenia | 301 | -9.1% |
| 49th | Moldova | 273 | -18.0% |
| 50th | Uzbekistan | 262 | -19.1% |
| 51st | Bulgaria | 249 | 18.0% |
| 52nd | Armenia | 226 | 67.4% |
| 53rd | Azerbaijan | 226 | -21.3% |
| 54th | Georgia | 222 | -10.5% |
| 55th | Philippines | 216 | -4.0% |
| 56th | Latvia | 206 | 48.2% |
| 57th | Viet Nam | 204 | -6.8% |
| 58th | Sri Lanka | 201 | 33.1% |
| 59th | Morocco | 177 | 18.0% |
| 60th | Hong Kong SAR, China | 173 | 8.1% |
| 61st | Pakistan | 170 | 56.0% |
| 62nd | Slovak Republic | 167 | -30.1% |
| 63rd | Kyrgyz Republic | 135 | -12.9% |
| 64th | Colombia | 126 | -1.6% |
| 65th | Lithuania | 87 | 40.3% |
| 66th | Tunisia | 76 | 0.0% |
| 67th | Cuba | 69 | -6.8% |
| 68th | Kenya | 63 | 53.7% |
| 69th | Estonia | 62 | 40.9% |
| 70th | Bangladesh | 60 | 106.9% |
| 71st | Bosnia and Herzegovina | 59 | 7.3% |
| 72nd | Iceland | 50 | -18.0% |
| 73rd | Jordan | 50 | -15.3% |
| 74th | Luxembourg | 48 | 220.0% |
| 75th | North Macedonia | 34 | -67.6% |
| 76th | Uruguay | 33 | -5.7% |
| 77th | Peru | 31 | 10.7% |
| 78th | Zambia | 26 | 36.8% |
| 79th | Costa Rica | 24 | 20.0% |
| 80th | Jamaica | 15 | 150.0% |
| 81st | Madagascar | 14 | 55.6% |
| 82nd | Malta | 14 | 40.0% |
| 83rd | Paraguay | 13 | -64.9% |
| 84th | Cyprus | 11 | 266.7% |
| 85th | Dominican Republic | 8 | -76.5% |
| 86th | Monaco | 7 | -36.4% |
| 87th | Guatemala | 5 | -44.4% |
| 88th | Macao SAR, China | 3 | 200.0% |
| 89th | Montenegro | 3 | - |
| 90th | Ecuador | 2 | -50.0% |
| 91st | Mozambique | 2 | -88.9% |
| 92nd | Mauritius | 2 | -33.3% |
| 93rd | Barbados | 1 | -66.7% |
| 94th | Lao PDR | 1 | -50.0% |
| 95th | Papua New Guinea | 1 | - |
| 96th | Trinidad and Tobago | 1 | -50.0% |
FAQ
Azerbaijan's patent applications in 2008 was 226. This ranked 53rd globally.
Azerbaijan's patent applications decreased by 21.3% in 2008 compared to 2007.
Japan had the highest patent applications in 2008 at 330,110.
The patent applications of Azerbaijan in 2008 was 226. This ranked 53rd globally.
Azerbaijan's patent applications went from 287 in 2007 to 226 in 2008, a 21.3% decrease.
Azerbaijan matched the Orthodox Tightening Cycle pattern in 2008. Historically: 311 occurrences, 177 successful (57%). Outcome 24 months later: 5.7%. View full analysis →